Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.

類似資料

• Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.
  出版事項: (2005-09-01)
• The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
  著者:: Chih-Jen Yang, 等
  出版事項: (2017-05-01)
• Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report
  著者:: Taiji Kuwata, 等
  出版事項: (2016-10-01)
• Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
  著者:: Wang Wen-Ping, 等
  出版事項: (2012-01-01)
• Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
  著者:: Yuan Ying, 等
  出版事項: (2012-11-01)